H.L. Ormond & Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$329K	Buy	1,139 +190	+20%	+$54.9K	0.53%	74
2022 Q2	$267K	Sell	949 -383	-29%	-$108K	0.43%	77
2022 Q1	$348K	Sell	1,332 -10	-0.7%	-$2.61K	0.42%	81
2021 Q4	$323K	Buy	+1,342	New	+$323K	0.38%	86